Platelet transfusion refractoriness (English Wikipedia)

Stanworth, Simon J.; Navarrete, Cristina; Estcourt, Lise; Marsh, Judith (2015). "Platelet refractoriness – practical approaches and ongoing dilemmas in patient management". British Journal of Haematology. 171 (3): 297–305. doi:10.1111/bjh.13597. ISSN 1365-2141. PMID 26194869. S2CID 9379017.
Hod, Eldad; Schwartz, Joseph (2008). "Platelet transfusion refractoriness". British Journal of Haematology. 142 (3): 348–360. doi:10.1111/j.1365-2141.2008.07189.x. ISSN 1365-2141. PMID 18510692. S2CID 42013955.
Slichter, Sherrill J.; Granger, Suzanne; Kaufman, Richard M.; Hess, John R.; Ness, P. M.; Strauss, Ronald G.; Assmann, Susan F.; Triulzi, Darrell J. (2012-06-07). "The impact of platelet transfusion characteristics on posttransfusion platelet increments and clinical bleeding in patients with hypoproliferative thrombocytopenia". Blood. 119 (23): 5553–5562. doi:10.1182/blood-2011-11-393165. ISSN 1528-0020. PMC 3369689. PMID 22496156.
Estcourt, Lise J; Malouf, Reem; Hopewell, Sally; Trivella, Marialena; Doree, Carolyn; Stanworth, Simon J; Murphy, Michael F (2017-07-30). "Pathogen-reduced platelets for the prevention of bleeding". Cochrane Database of Systematic Reviews. 7 (9): CD009072. doi:10.1002/14651858.cd009072.pub3. ISSN 1465-1858. PMC 5558872. PMID 28756627.
Pavenski, Katerina; Freedman, John; Semple, J. W. (2012). "HLA alloimmunization against platelet transfusions: pathophysiology, significance, prevention and management". Tissue Antigens. 79 (4): 237–245. doi:10.1111/j.1399-0039.2012.01852.x. ISSN 1399-0039. PMID 22385314.
Rebulla, P. (1993). "Formulae for the definition of refractoriness to platelet transfusion". Transfusion Medicine. 3 (1): 91–92. doi:10.1111/j.1365-3148.1993.tb00108.x. ISSN 1365-3148. PMID 8038900. S2CID 555511.
Cohn CS (December 2020). "Platelet transfusion refractoriness: how do I diagnose and manage?". Hematology Am Soc Hematol Educ Program. 2020 (1): 527–532. doi:10.1182/hematology.2020000137. PMC 7727584. PMID 33275694.
Nahirniak, Susan; Slichter, Sherrill J.; Tanael, Susano; Rebulla, Paolo; Pavenski, Katerina; Vassallo, Ralph; Fung, Mark; Duquesnoy, Rene; Saw, Chee-Loong (2015). "Guidance on platelet transfusion for patients with hypoproliferative thrombocytopenia". Transfusion Medicine Reviews. 29 (1): 3–13. doi:10.1016/j.tmrv.2014.11.004. ISSN 1532-9496. PMID 25537844.
Pavenski, Katerina; Rebulla, Paolo; Duquesnoy, Rene; Saw, Chee Loong; Slichter, Sherrill J.; Tanael, Susano; Shehata, Nadine (2013). "Efficacy of HLA-matched platelet transfusions for patients with hypoproliferative thrombocytopenia: a systematic review". Transfusion. 53 (10): 2230–2242. doi:10.1111/trf.12175. ISSN 1537-2995. PMID 23550773. S2CID 1839654.
Satapathy SK, Sundaram V, Shiffman ML, Jamieson BD (October 2023). "Real-world use of avatrombopag in patients with chronic liver disease and thrombocytopenia undergoing a procedure". Medicine (Baltimore). 102 (40): e35208. doi:10.1097/MD.0000000000035208. PMC 10553023. PMID 37800793.
Vo P, Purev E, West KA, McDuffee E, Worthy T, Cook L, Hawks G, Wells B, Shalabi R, Flegel WA, Adams SD, Reger R, Aue G, Tian X, Childs R (May 2020). "A pilot trial of complement inhibition using eculizumab to overcome platelet transfusion refractoriness in human leukocyte antigen allo-immunized patients". Br J Haematol. 189 (3): 551–558. doi:10.1111/bjh.16385. PMC 7192788. PMID 32086819.
Habibi A, Esfandbod M, Ghafari MH, Khashayar P, Najafi A, Moharari RS (August 2011). "Platelet kinetics after slow versus standard transfusions: a pilot study". Ups J Med Sci. 116 (3): 212–5. doi:10.3109/03009734.2011.569588. PMC 3128726. PMID 21679106.

nih.gov

pubmed.ncbi.nlm.nih.gov

Stanworth, Simon J.; Navarrete, Cristina; Estcourt, Lise; Marsh, Judith (2015). "Platelet refractoriness – practical approaches and ongoing dilemmas in patient management". British Journal of Haematology. 171 (3): 297–305. doi:10.1111/bjh.13597. ISSN 1365-2141. PMID 26194869. S2CID 9379017.
Hod, Eldad; Schwartz, Joseph (2008). "Platelet transfusion refractoriness". British Journal of Haematology. 142 (3): 348–360. doi:10.1111/j.1365-2141.2008.07189.x. ISSN 1365-2141. PMID 18510692. S2CID 42013955.
Slichter, Sherrill J.; Granger, Suzanne; Kaufman, Richard M.; Hess, John R.; Ness, P. M.; Strauss, Ronald G.; Assmann, Susan F.; Triulzi, Darrell J. (2012-06-07). "The impact of platelet transfusion characteristics on posttransfusion platelet increments and clinical bleeding in patients with hypoproliferative thrombocytopenia". Blood. 119 (23): 5553–5562. doi:10.1182/blood-2011-11-393165. ISSN 1528-0020. PMC 3369689. PMID 22496156.
Estcourt, Lise J; Malouf, Reem; Hopewell, Sally; Trivella, Marialena; Doree, Carolyn; Stanworth, Simon J; Murphy, Michael F (2017-07-30). "Pathogen-reduced platelets for the prevention of bleeding". Cochrane Database of Systematic Reviews. 7 (9): CD009072. doi:10.1002/14651858.cd009072.pub3. ISSN 1465-1858. PMC 5558872. PMID 28756627.
Rebulla, Paolo (2005). "A mini-review on platelet refractoriness". Haematologica. 90 (2): 247–253. ISSN 1592-8721. PMID 15710579.
Pavenski, Katerina; Freedman, John; Semple, J. W. (2012). "HLA alloimmunization against platelet transfusions: pathophysiology, significance, prevention and management". Tissue Antigens. 79 (4): 237–245. doi:10.1111/j.1399-0039.2012.01852.x. ISSN 1399-0039. PMID 22385314.
Rebulla, P. (1993). "Formulae for the definition of refractoriness to platelet transfusion". Transfusion Medicine. 3 (1): 91–92. doi:10.1111/j.1365-3148.1993.tb00108.x. ISSN 1365-3148. PMID 8038900. S2CID 555511.
Cohn CS (December 2020). "Platelet transfusion refractoriness: how do I diagnose and manage?". Hematology Am Soc Hematol Educ Program. 2020 (1): 527–532. doi:10.1182/hematology.2020000137. PMC 7727584. PMID 33275694.
Nahirniak, Susan; Slichter, Sherrill J.; Tanael, Susano; Rebulla, Paolo; Pavenski, Katerina; Vassallo, Ralph; Fung, Mark; Duquesnoy, Rene; Saw, Chee-Loong (2015). "Guidance on platelet transfusion for patients with hypoproliferative thrombocytopenia". Transfusion Medicine Reviews. 29 (1): 3–13. doi:10.1016/j.tmrv.2014.11.004. ISSN 1532-9496. PMID 25537844.
Pavenski, Katerina; Rebulla, Paolo; Duquesnoy, Rene; Saw, Chee Loong; Slichter, Sherrill J.; Tanael, Susano; Shehata, Nadine (2013). "Efficacy of HLA-matched platelet transfusions for patients with hypoproliferative thrombocytopenia: a systematic review". Transfusion. 53 (10): 2230–2242. doi:10.1111/trf.12175. ISSN 1537-2995. PMID 23550773. S2CID 1839654.
Satapathy SK, Sundaram V, Shiffman ML, Jamieson BD (October 2023). "Real-world use of avatrombopag in patients with chronic liver disease and thrombocytopenia undergoing a procedure". Medicine (Baltimore). 102 (40): e35208. doi:10.1097/MD.0000000000035208. PMC 10553023. PMID 37800793.
Vo P, Purev E, West KA, McDuffee E, Worthy T, Cook L, Hawks G, Wells B, Shalabi R, Flegel WA, Adams SD, Reger R, Aue G, Tian X, Childs R (May 2020). "A pilot trial of complement inhibition using eculizumab to overcome platelet transfusion refractoriness in human leukocyte antigen allo-immunized patients". Br J Haematol. 189 (3): 551–558. doi:10.1111/bjh.16385. PMC 7192788. PMID 32086819.
Habibi A, Esfandbod M, Ghafari MH, Khashayar P, Najafi A, Moharari RS (August 2011). "Platelet kinetics after slow versus standard transfusions: a pilot study". Ups J Med Sci. 116 (3): 212–5. doi:10.3109/03009734.2011.569588. PMC 3128726. PMID 21679106.

ncbi.nlm.nih.gov

Slichter, Sherrill J.; Granger, Suzanne; Kaufman, Richard M.; Hess, John R.; Ness, P. M.; Strauss, Ronald G.; Assmann, Susan F.; Triulzi, Darrell J. (2012-06-07). "The impact of platelet transfusion characteristics on posttransfusion platelet increments and clinical bleeding in patients with hypoproliferative thrombocytopenia". Blood. 119 (23): 5553–5562. doi:10.1182/blood-2011-11-393165. ISSN 1528-0020. PMC 3369689. PMID 22496156.
Estcourt, Lise J; Malouf, Reem; Hopewell, Sally; Trivella, Marialena; Doree, Carolyn; Stanworth, Simon J; Murphy, Michael F (2017-07-30). "Pathogen-reduced platelets for the prevention of bleeding". Cochrane Database of Systematic Reviews. 7 (9): CD009072. doi:10.1002/14651858.cd009072.pub3. ISSN 1465-1858. PMC 5558872. PMID 28756627.
Cohn CS (December 2020). "Platelet transfusion refractoriness: how do I diagnose and manage?". Hematology Am Soc Hematol Educ Program. 2020 (1): 527–532. doi:10.1182/hematology.2020000137. PMC 7727584. PMID 33275694.
Satapathy SK, Sundaram V, Shiffman ML, Jamieson BD (October 2023). "Real-world use of avatrombopag in patients with chronic liver disease and thrombocytopenia undergoing a procedure". Medicine (Baltimore). 102 (40): e35208. doi:10.1097/MD.0000000000035208. PMC 10553023. PMID 37800793.
Vo P, Purev E, West KA, McDuffee E, Worthy T, Cook L, Hawks G, Wells B, Shalabi R, Flegel WA, Adams SD, Reger R, Aue G, Tian X, Childs R (May 2020). "A pilot trial of complement inhibition using eculizumab to overcome platelet transfusion refractoriness in human leukocyte antigen allo-immunized patients". Br J Haematol. 189 (3): 551–558. doi:10.1111/bjh.16385. PMC 7192788. PMID 32086819.
Habibi A, Esfandbod M, Ghafari MH, Khashayar P, Najafi A, Moharari RS (August 2011). "Platelet kinetics after slow versus standard transfusions: a pilot study". Ups J Med Sci. 116 (3): 212–5. doi:10.3109/03009734.2011.569588. PMC 3128726. PMID 21679106.

semanticscholar.org

api.semanticscholar.org

Stanworth, Simon J.; Navarrete, Cristina; Estcourt, Lise; Marsh, Judith (2015). "Platelet refractoriness – practical approaches and ongoing dilemmas in patient management". British Journal of Haematology. 171 (3): 297–305. doi:10.1111/bjh.13597. ISSN 1365-2141. PMID 26194869. S2CID 9379017.
Hod, Eldad; Schwartz, Joseph (2008). "Platelet transfusion refractoriness". British Journal of Haematology. 142 (3): 348–360. doi:10.1111/j.1365-2141.2008.07189.x. ISSN 1365-2141. PMID 18510692. S2CID 42013955.
Rebulla, P. (1993). "Formulae for the definition of refractoriness to platelet transfusion". Transfusion Medicine. 3 (1): 91–92. doi:10.1111/j.1365-3148.1993.tb00108.x. ISSN 1365-3148. PMID 8038900. S2CID 555511.
Pavenski, Katerina; Rebulla, Paolo; Duquesnoy, Rene; Saw, Chee Loong; Slichter, Sherrill J.; Tanael, Susano; Shehata, Nadine (2013). "Efficacy of HLA-matched platelet transfusions for patients with hypoproliferative thrombocytopenia: a systematic review". Transfusion. 53 (10): 2230–2242. doi:10.1111/trf.12175. ISSN 1537-2995. PMID 23550773. S2CID 1839654.

transfusion.com.au

"transfusion.com.au". transfusion.com.au. Retrieved 2018-12-28.

transfusionguidelines.org

"Platelets, Apheresis, Leucocyte Depleted". www.transfusionguidelines.org. Retrieved 2018-12-29.
"Platelets, Pooled, Buffy Coat Derived, in Additive Solution and Plasma, Leucocyte Depleted". www.transfusionguidelines.org. Retrieved 2018-12-29.

web.archive.org

"Guidelines for the management of platelet transfusion refractoriness" (PDF). hospital.blood.co.uk. Archived from the original (PDF) on 2018-12-20. Retrieved 2018-12-28.

worldcat.org

search.worldcat.org

Stanworth, Simon J.; Navarrete, Cristina; Estcourt, Lise; Marsh, Judith (2015). "Platelet refractoriness – practical approaches and ongoing dilemmas in patient management". British Journal of Haematology. 171 (3): 297–305. doi:10.1111/bjh.13597. ISSN 1365-2141. PMID 26194869. S2CID 9379017.
Hod, Eldad; Schwartz, Joseph (2008). "Platelet transfusion refractoriness". British Journal of Haematology. 142 (3): 348–360. doi:10.1111/j.1365-2141.2008.07189.x. ISSN 1365-2141. PMID 18510692. S2CID 42013955.
Slichter, Sherrill J.; Granger, Suzanne; Kaufman, Richard M.; Hess, John R.; Ness, P. M.; Strauss, Ronald G.; Assmann, Susan F.; Triulzi, Darrell J. (2012-06-07). "The impact of platelet transfusion characteristics on posttransfusion platelet increments and clinical bleeding in patients with hypoproliferative thrombocytopenia". Blood. 119 (23): 5553–5562. doi:10.1182/blood-2011-11-393165. ISSN 1528-0020. PMC 3369689. PMID 22496156.
Estcourt, Lise J; Malouf, Reem; Hopewell, Sally; Trivella, Marialena; Doree, Carolyn; Stanworth, Simon J; Murphy, Michael F (2017-07-30). "Pathogen-reduced platelets for the prevention of bleeding". Cochrane Database of Systematic Reviews. 7 (9): CD009072. doi:10.1002/14651858.cd009072.pub3. ISSN 1465-1858. PMC 5558872. PMID 28756627.
Rebulla, Paolo (2005). "A mini-review on platelet refractoriness". Haematologica. 90 (2): 247–253. ISSN 1592-8721. PMID 15710579.
Pavenski, Katerina; Freedman, John; Semple, J. W. (2012). "HLA alloimmunization against platelet transfusions: pathophysiology, significance, prevention and management". Tissue Antigens. 79 (4): 237–245. doi:10.1111/j.1399-0039.2012.01852.x. ISSN 1399-0039. PMID 22385314.
Rebulla, P. (1993). "Formulae for the definition of refractoriness to platelet transfusion". Transfusion Medicine. 3 (1): 91–92. doi:10.1111/j.1365-3148.1993.tb00108.x. ISSN 1365-3148. PMID 8038900. S2CID 555511.
Nahirniak, Susan; Slichter, Sherrill J.; Tanael, Susano; Rebulla, Paolo; Pavenski, Katerina; Vassallo, Ralph; Fung, Mark; Duquesnoy, Rene; Saw, Chee-Loong (2015). "Guidance on platelet transfusion for patients with hypoproliferative thrombocytopenia". Transfusion Medicine Reviews. 29 (1): 3–13. doi:10.1016/j.tmrv.2014.11.004. ISSN 1532-9496. PMID 25537844.
Pavenski, Katerina; Rebulla, Paolo; Duquesnoy, Rene; Saw, Chee Loong; Slichter, Sherrill J.; Tanael, Susano; Shehata, Nadine (2013). "Efficacy of HLA-matched platelet transfusions for patients with hypoproliferative thrombocytopenia: a systematic review". Transfusion. 53 (10): 2230–2242. doi:10.1111/trf.12175. ISSN 1537-2995. PMID 23550773. S2CID 1839654.